INTLsp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2009-03-20
Share capital
5,000.00 PLN
Registered address
Skalista 54C, 25-435 Kielce, Poland
Financials
Revenue history
Filing timeliness
Financial statements were filed on time, on average 61 days early.
- 202502/04/2026
- 202401/07/2025
- 202315/07/2024
- 202219/05/2023
- 202120/05/2022
- 202001/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 318.18MedianUSD 152.85kAverageUSD 4.86m
Net profit
This companyUSD -2.19kMedianUSD -228.23AverageUSD 317.06k
Operating costs
This companyUSD 2.51kMedianUSD 187.91kAverageUSD 4.67m
Assets
This companyUSD 10.56kMedianUSD 278.35kAverageUSD 8.47m
Industry
Authorized Representatives
Aleksander Chmielewski – President
Koenraad Cruycke – President
Manner of representation
Authorised to submit declarations of will and sign on behalf of the company are the members of the management board individually.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Aleksander Chmielewskiage 56 | 25 | $337.66 | 25% |
Koenraad Cruyckeage 61 | 50 | $675.31 | 50% |
Krzysztof Panekage 56 | 25 | $337.66 | 25% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2009-03-03.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 26, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Kielce |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Digital Pathology Teamsp. z o.o. | $64,552.91 | digitalpathologyteam.com | ||
| Nextgen Materialssp. z o.o. | $367.20 | fruitonauts.com | ||
| Verilabssp. z o.o. | $267.69 | veripet.pl | ||
| NanotheaS.A. | $115.78 | nanothea.com | ||
| Alsitechsp. z o.o. | $106.21 | alsitech.pl | ||
| Genovaris Medicalsp. z o.o. | $25.11 | genovaris.com | ||
| MolecureS.A. | $10.77 | molecure.com | ||
| Toptech R&Dsp. z o.o. | $0.21 | toptechpolska.pl | ||
| Greta Circlesp. z o.o. | – | gretacircle.com | ||
| Voltified Energysp. z o.o. | – | voltified.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-02-19 | Switch to PKD 2025 (55 PKD 2007 codes → 1 PKD 2025 code) | |
| 2011-10-31 | Name change (Dwa → Intl) | |
| 2011-05-24 | Address change (Słowackiego 12, 25-365, Kielce → Skalista 54c, 25-435, Kielce) | |
| 2009-03-20 | Entered in the register |
FAQ
The main business activity of Intl focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on March 20, 2009.
The headquarters is located at: Skalista 54C, 25-435 Kielce.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $318.
No, the company recorded a net loss of $2,189 in 2025. For comparison, in 2024 the loss was $1,593, meaning the company increased its loss by 37.1%.
The largest operating cost category falls under other operating costs. This category amounted to $2,507 in 2025, representing 100% of all operating expenses.
Last updated: 2026-04-03